Wellington Management Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
DM
VPM
VCM
FFM
RI
TCM
Wellington Management Group's COGT Position: Q1 2026 in Review
Wellington Management Group increased its Cogent Biosciences (COGT) stake by 32% in Q1 2026, buying an estimated $32M and bringing the position to 3,578,622 shares worth $138M. The position accounts for 0.03% of the portfolio, ranked #463.
Wellington Management Group first reported a position in COGT in Q1 2018 and has held it in 17 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.
- Wellington Management Group held 3,578,622 shares of Cogent Biosciences worth $138M as of Q1 2026.
- Wellington Management Group bought 866,286 Cogent Biosciences shares in Q1 2026, an estimated $32M.
- Cogent Biosciences made up 0.03% of Wellington Management Group's portfolio in Q1 2026, its #463 holding.
- Wellington Management Group first reported a position in Cogent Biosciences in Q1 2018 and has held it in 17 quarters since.
- 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.